Prescription Niacin Tablets Recalled for Microbial Contamination
Sun Pharmaceutical is recalling Niacin Extended-Release Tablets nationwide due to microbial contamination found in manufacturing equipment. Affected lot numbers expire in June and July 2025.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with unspecified microbial contamination and no reported illnesses or injuries. Without identification of a named high-risk pathogen or evidence of harm, this meets criteria for Moderate severity.
Plain-English summary
Sun Pharmaceutical Industries Inc. is recalling Niacin Extended-Release Tablets, USP 500mg, due to microbial contamination discovered during manufacturing. Specifically, microbial contamination was found in stagnant water in equipment ducts, which violates Current Good Manufacturing Practices (CGMP).
The recall affects 15,768 bottles distributed nationwide in the United States. The affected lot numbers are: DNE0771A (expiration 06/30/2025), DNE0857A, and DNE0959A (expiration 07/31/2025). The product is a prescription-only medication.
Patients taking affected lots should consult their healthcare provider or pharmacist for guidance. Pharmacies should verify their inventory against the recalled lot numbers and quarantine any affected stock.
The recalled product
- Product
- NIACIN (NIACIN)
- Brand
- NIACIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Prescription Vitamin
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: DNE0771A Exp. 06/30/2025
- DNE0857A
- DNE0959A Exp. 07/31/2025.
UPCs (3)
- 0347335613810
- 0347335614817
- 0347335539813
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NIACIN
- HighNiacin Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-11-26
- ModeratePrescription Niacin Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-29
- HighNiacin Extended-Release Tablets Recalled for Manufacturing Microbial Contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27